MRC1 and acquired polycythemia vera: In conclusion, the overall germline PV positive rate of abnormal IHC in a population of patients with Lynch-associated cancer types who were referred to a clinical molecular diagnostic lab is approximately 20%, and nearly 2% of these individuals carried a germline PV in an MMR gene that was not consistent with the IHC result.